Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma
A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for ...
Discover key gene signatures that could help predict the efficacy of immune checkpoint blockade therapy in patients with ...
Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it ...
Patients with gallbladder cancer and cholangiocarcinoma may benefit from receiving Avastin plus Tarceva versus active ...
Corcept could be significantly undervalued based on long term potential growth and science-based innovation. Find out why ...
Patients with limited-stage SCLC were randomly assigned to receive durvalumab with or without tremelimumab or placebo as ...
For a subset of patients with inoperable or metastatic HR-positive/HER2-negative breast cancer, treatment with datopotamab ...
Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent GlioblastomaCohort A Data ...
A new combination therapy of lurbinectedin and atezolizumab showed promising results in improving overall survival and ...
Locally advanced cervical cancer remains a substantial source of mortality, particularly in low-resource settings.1 ...
Adding nivolumab (Opdivo) instead of brentuximab vedotin (Adcetris) to the standard chemotherapy backbone of doxorubicin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback